US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 9.060
  • -0.375-3.97%
Close Feb 28 16:00 ET
  • 9.060
  • 0.0000.00%
Post 20:01 ET
918.27MMarket Cap-8.88P/E (TTM)

About Day One Biopharmaceuticals Company

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.

Company Profile

SymbolDAWN
Company NameDay One Biopharmaceuticals
Listing DateMay 27, 2021
Issue Price16.00
Founded2018
CEODr. Jeremy Bender, M.B.A.,PhD
MarketNASDAQ
Employees181
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 501
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-484-0899
Websitehttp://www.dayonebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jeremy Bender, M.B.A.,PhD
  • Chief Executive Officer, President and Director
  • 6.91M
  • Charles N. York, II
  • Principal Accounting Officer, Chief Operating Officer and Chief Financial Officer
  • 3.55M
  • Adam Dubow
  • General Counsel and Chief Compliance Officer
  • 2.77M
  • Garry A. Nicholson
  • Chairman of the Board
  • 383.38K
  • Dr. William Grossman, M.D.,PhD
  • Director
  • --
  • Habib Joseph Dable
  • Director
  • --
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 351.75K
  • Scott Garland
  • Independent Director
  • 342.88K
  • Dr. John A. Josey, PhD
  • Independent Director
  • 350.75K
  • Natalie C. Holles
  • Lead Independent Director
  • 352.50K
  • Michael Gladstone
  • Independent Director
  • 342.88K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!